[Multicomponent therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline].

Published

Journal Article (Review)

BACKGROUND: The scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND METHODS: The development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND CONCLUSION: The use of a multicomponent therapy (the combination of aerobic exercise with at least one psychological therapy) for a minimum of 24 h is strongly recommended for patients with severe FMS. The English full-text version of this article is available at SpringerLink (under "Supplemental").

Full Text

Duke Authors

Cited Authors

  • Arnold, B; Häuser, W; Arnold, M; Bernateck, M; Bernardy, K; Brückle, W; Friedel, E; Hesselschwerdt, HJ; Jäckel, W; Köllner, V; Kühn, E; Petzke, F; Settan, M; Weigl, M; Winter, E; Offenbächer, M; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften,

Published Date

  • June 2012

Published In

Volume / Issue

  • 26 / 3

Start / End Page

  • 287 - 290

PubMed ID

  • 22760461

Pubmed Central ID

  • 22760461

Electronic International Standard Serial Number (EISSN)

  • 1432-2129

Digital Object Identifier (DOI)

  • 10.1007/s00482-012-1173-1

Language

  • ger

Conference Location

  • Germany